Mometason Pollen Sandoz
Mometason Pollen Sandoz is a medicine authorised by Swissmedic under authorisation number 66274. The authorisation holder is Sandoz Pharmaceuticals AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 11 August 2017 and the authorisation is valid without a time limit. The export lists no ATC code for this medicine.
| Authorisation number | 66274 |
|---|---|
| Name | Mometason Pollen Sandoz |
| Full name | Mometason Pollen Sandoz, Nasenspray |
| Authorisation holder | Sandoz Pharmaceuticals AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | not stated |
| First authorisation | 11 August 2017 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Mometason Pollen Sandoz, Nasenspray | B | 11 August 2017 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| The Swissmedic export lists no pack sizes for this medicine. | |||||
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Mometason Pollen Sandoz authorised in Switzerland?
Yes. Mometason Pollen Sandoz is authorised by Swissmedic under authorisation number 66274, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Mometason Pollen Sandoz have?
Mometason Pollen Sandoz is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Mometason Pollen Sandoz?
The authorisation holder is Sandoz Pharmaceuticals AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.